Relay Therapeutics, Inc. (RLAY) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Relay Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • Relay Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $300 M, a 30.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $300 M +$69.3 M +30.1% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $231 M +$87.8 M +61.6% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $143 M +$76.9 M +117% Dec 31, 2021 10-K 2023-02-23
Q4 2020 $65.8 M +$14.3 M +27.7% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $51.5 M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.